Your browser doesn't support javascript.
loading
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].
Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S.
Affiliation
  • Gil-Jimenez A; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.
  • van Dorp J; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Contreras-Sanz A; The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • van der Vos K; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vis DJ; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.
  • Braaf L; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Broeks A; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kerkhoven R; Core Facility Genomics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Kessel KEM; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Ribal MJ; Laboratory and Department of Urology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Universitat de Barcelona, Barcelona, Spain.
  • Alcaraz A; Laboratory and Department of Urology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Universitat de Barcelona, Barcelona, Spain.
  • Wessels LFA; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands.
  • Seiler R; Department of BioMedical Research, University of Bern, Bern, Switzerland; Department of Urology, Hospital Center Biel, Biel, Switzerland.
  • Wright JL; Department of Urology, University of Washington School of Medicine, Seattle, WA, USA.
  • Mengual L; Laboratory and Department of Urology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Universitat de Barcelona, Barcelona, Spain.
  • Boormans J; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
  • Black PC; The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • van der Heijden MS; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: ms.vd.heijden@nki.nl.
Eur Urol ; 83(6): e165, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36907692
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Country of publication: